# thymulin: Workshop Reference on the Zinc-Dependent Thymic Nonapeptide

> thymulin is a nine-amino-acid thymic hormone whose biological activity requires zinc binding. Peer-reviewed research summaries on T-cell differentiation, immune modulation, and analgesic activity — cited at the source.

## What is thymulin

thymulin (Facteur Thymique Serique, FTS) is a nonapeptide — a chain of nine amino acids, sequence Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — produced exclusively by the epithelial cells of the thymus gland [3]. Its molecular weight is 858.8 Da. The defining structural feature: thymulin requires an equimolar zinc ion to achieve the three-dimensional conformation that makes it biologically active. Remove the zinc, and the peptide is inert [1].

In that sense, thymulin is a metallopeptide — a machine that needs a specific metal part to run. The zinc binds at a dissociation constant of approximately 5 × 10⁻⁷ M at pH 7.4; activity drops to zero below pH 6.0 [1]. This zinc-dependency is not incidental: it is the mechanism by which the body's zinc status directly gates thymic immune output.

From birth, thymulin circulates in serum and acts on T-cell precursors in the thymus, driving expression of surface differentiation markers CD2, CD3, CD4, and CD8 [3]. Beyond the thymus, thymulin functions as a hypophysiotropic signal, stimulating ACTH, LH, and other pituitary hormones through cyclic AMP and cyclic GMP second-messenger pathways [11].

Serum thymulin titres follow a predictable lifespan trajectory: peak in children aged 5–10 years (mean titre 4.77), progressive decline from adolescence, nadir at age 36 (mean titre 0.66), stable through the oldest subjects tested at age 80 (mean 0.55 ± 0.16) [2]. This decline is partially a zinc-sufficiency problem: in aged mice, the primary defect is reduced zinc saturation of the peptide rather than absent synthesis, and zinc addition to thymic cultures from 24-month-old animals fully restores zinc-bound thymulin levels [5].

## Thymulin Research: Studied Benefits and Biological Roles

The thymulin research record documents effects across four domains: immune maturation, inflammation control, analgesic activity, and — in preclinical models — neuroendocrine regulation.

**T-cell maturation and NK cell activity.** Thymulin is the primary thymic signal for T-lymphocyte differentiation, inducing CD2, CD3, CD4, and CD8 surface markers on thymocyte precursors [3]. In chickens infected with infectious bronchitis virus, thymulin treatment at 10 ng/100g body weight enhanced natural killer cell cytotoxicity in a dose-dependent manner at 10 days post-infection, measured by ⁵¹Cr-release assay [10]. The same model found that high-dose thymulin (50 ng/100g) paradoxically depressed NK activity relative to low dose — a bidirectional response that appears in several immune-modulation studies and underscores the precision required in immune research protocols [10].

**Cytokine suppression and anti-inflammatory activity.** At 15 μg/100g body weight intraperitoneally, thymulin prevented accumulation of IL-1β, IL-2, IL-6, TNF-α, and IFN-γ in LPS-treated mice and suppressed the LPS-induced Hsp70 peak in immune cells [9]. In a relapsing-remitting EAE mouse model, PBCA nanoparticle-encapsulated thymulin at 1.5 mg/kg every other day for 25 days achieved complete disease restoration in treated animals [13].

**Analgesic and neuroinflammatory effects.** A peptide analogue of thymulin (PAT) reduced mechanical and thermal hyperalgesia induced by endotoxin in rats at doses of 25 μg intraperitoneally — effects comparable to dexamethasone and indomethacin [6]. In neuropathic pain models, daily PAT treatment progressively attenuated mechanical allodynia and heat hyperalgesia [7].

**Neuroendocrine signaling.** Thymulin-Zn²⁺ stimulated ACTH release from rat anterior pituitary cells in vitro at maximum effect at 10 pM, with smaller increases in LH, elevated cyclic AMP and GMP, and inhibited prolactin [11].

## Thymulin Peptide Benefits in Preclinical Models

Across the indexed studies, four categories of thymulin peptide benefit appear in preclinical models:

1. **Immune reconstitution.** In zinc-deficient human subjects, oral zinc repletion restored active thymulin, corrected T4⁺/T8⁺ ratios, and normalized IL-2 activity [4].
2. **Cytokine balance modulation.** Thymulin suppresses the pro-inflammatory cytokine cascade — IL-1β, IL-6, TNF-α, IFN-γ — via NF-kB and MAPK/p38 pathway inhibition [9, 13].
3. **Analgesic effects.** PAT (a thymulin analogue) demonstrated pain-threshold restoration comparable to NSAID comparators at 25 μg intraplantar dosing in rodent inflammatory and neuropathic pain models [6, 7, 8].
4. **Hair follicle activity (topical Zn-thymulin).** In a pilot open-label human study (n=18, androgenetic alopecia, Norwood 2–7), topical zinc-thymulin spray was associated with a 32% mean increase in vellus-type hairs and a 23% increase in intermediate-type hairs over 4–10 months, with no adverse systemic effects [17].

## What is thymulin?

A nine-amino-acid (nonapeptide) hormone secreted by thymic epithelial cells, thymulin acts as a circulating immune signal — particularly for T-lymphocyte maturation and cytokine regulation. Its full name is Facteur Thymique Serique (FTS); it is also called Zn-FTS in its zinc-bound bioactive form. Molecular weight: 858.8 Da. Sequence: Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn [1, 3].

## References

[1] Dardenne M, Pleau JM. Interactions Between Zinc and Thymulin. Metal-Based Drugs. 1994;1(4):233-249. DOI: 10.1155/MBD.1994.233
[2] Consolini R, et al. Distribution of age-related thymulin titres in normal subjects through the course of life. Clin Exp Immunol. 2000;121(3):444-7. DOI: 10.1046/j.1365-2249.2000.01315.x
[3] Reggiani PC, et al. The Thymus-Neuroendocrine Axis. Ann N Y Acad Sci. 2009;1153:98-106. DOI: 10.1111/j.1749-6632.2008.03964.x
[4] Prasad AS, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988;82(4):1202-10. DOI: 10.1172/JCI113717
[5] Mocchegiani E, Fabris N. Age-related thymus involution: zinc reverses in vitro the thymulin secretion defect. Int J Immunopharmacol. 1995;17(9):745-9. DOI: 10.1016/0192-0561(95)00064-9
[6] Safieh-Garabedian B, et al. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. Br J Pharmacol. 2002;136(7):947-55. DOI: 10.1038/sj.bjp.0704793
[7] Saade NE, et al. A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin. Neuroscience. 2003;119(2):529-40. DOI: 10.1016/s0306-4522(03)00072-1
[8] Safieh-Garabedian B, et al. Thymulin reverses inflammatory hyperalgesia. Neuroscience. 2003;122(4):1049-61. DOI: 10.1016/s0306-4522(03)00500-1
[9] Lunin SM, et al. Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines. Immunol Invest. 2008;37(8):858-71. DOI: 10.1080/08820130802447629
[10] Oliver MA, Marsh JA. In vivo thymulin treatments enhance avian lung natural killer cell cytotoxicity. Int Immunopharmacol. 2003;3(3):271-80. DOI: 10.1016/s1567-5769(02)00236-9
[11] Hadley AJ, et al. Thymulin stimulates corticotrophin release. Neuroimmunomodulation. 1997;4(2):62-9. DOI: 10.1159/000097322
[13] Lunin SM, et al. Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against Relapsing-Remitting EAE. Int J Mol Sci. 2019;20(21):5374. DOI: 10.3390/ijms20215374
[17] Vickers ER. An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia. Hair Ther Transplant. 2017;7:147. DOI: 10.4172/2167-0951.1000147
[18] Reggiani PC, et al. Physiology and therapeutic potential of the thymic peptide thymulin. Curr Pharm Des. 2014;20(29):4690-6. DOI: 10.2174/1381612820666140130211157

---

A machinist's indexed reference for the zinc-thymulin record — mechanism assembled part by part from the published literature, no clinic behind the rivets.